Once‐Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

20251 citationsReviewgold Open Access

Authors

H. Mehmood · Alexandra Hospital

Moaz Alowami · Libyan International Medical University

Thaung Hlaing · Nevill Hall Hospital

Khant Nyi Zaya · Velindre Cancer Centre

Yousrah Uraiby · University of Alabama at Birmingham Hospital

Aftab Alam · Masaryk University

Abubakr Adala ·

Abstract

Once-weekly efsitora provides comparable glycaemic control and improved time-in-range compared to daily insulin, although with a higher rate of TEAEs.

Topics & Keywords

Diabetes Management and Research Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Treatment and Management

Publication Details

Published in: Endocrinology Diabetes & Metabolism

Volume 8, Issue 6, pp. e70126-e70126

DOI: 10.1002/edm2.70126

Field-Weighted Citation Impact: 1.36

Command Palette

Once‐Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Authors

Abstract

Topics & Keywords

Publication Details